Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • EdU Flow Cytometry Assay Kits (Cy5): Precision S-Phase DN...

    2025-12-03

    EdU Flow Cytometry Assay Kits (Cy5): Precision S-Phase DNA Synthesis Analysis

    Executive Summary: The EdU Flow Cytometry Assay Kits (Cy5) (SKU K1078) provide highly sensitive and specific detection of S-phase DNA synthesis using 5-ethynyl-2'-deoxyuridine (EdU) incorporation and Cy5-based click chemistry (APExBIO). This method eliminates harsh denaturation steps required by BrdU, enabling preservation of cell surface and intracellular antigenicity. The workflow is optimized for flow cytometry, supporting multiplexing and high-throughput analysis. These attributes are critical for reproducible cell proliferation studies, as demonstrated in recent peer-reviewed research involving cell cycle and genotoxicity assessments (Xiao et al., 2025). APExBIO's kit sets a reliable standard for biomedical research applications across oncology, toxicology, and regenerative medicine.

    Biological Rationale

    Cell proliferation is a hallmark of tissue development, regeneration, and malignancy. Accurate quantification of proliferating cells informs studies of cancer progression, wound healing, and pharmacodynamic responses (Xiao et al., 2025). During S-phase, cells synthesize DNA, providing a window for measuring proliferation by tracking nucleoside analog incorporation. Traditional assays, such as BrdU labeling, require DNA denaturation, which can compromise antigenicity and cellular integrity. EdU (5-ethynyl-2'-deoxyuridine) is a thymidine analog that incorporates into DNA during replication without altering cell cycle dynamics [internal review]. The small alkyne moiety of EdU allows for subsequent detection via copper-catalyzed azide-alkyne cycloaddition (CuAAC, "click chemistry"), resulting in a covalent linkage to a fluorescent azide dye, such as Cy5.

    Mechanism of Action of EdU Flow Cytometry Assay Kits (Cy5)

    The EdU Flow Cytometry Assay Kits (Cy5) utilize a two-step protocol. First, EdU is added to proliferating cells, where it is incorporated into newly synthesized DNA during the S-phase. Second, fixed and permeabilized cells are subjected to a click reaction: the alkyne group of EdU forms a stable 1,2,3-triazole linkage with a Cy5-conjugated azide in the presence of copper sulfate (CuSO4), DMSO, and buffer additive. This approach generates a robust fluorescent signal at 650 nm (Cy5 emission), directly reflecting DNA synthesis. Unlike BrdU, no harsh acid or heat treatment is needed, which maintains the structure of cellular proteins and epitopes for antibody co-staining. The kit is optimized for flow cytometry, achieving low background and high sensitivity under recommended conditions (incubation at 37°C, pH 7.4, reaction time 30 minutes).

    Evidence & Benchmarks

    • EdU-based click chemistry enables rapid and specific labeling of S-phase cells in mammalian systems, outperforming BrdU in preserving antigenicity (Xiao et al., 2025, DOI:10.4239/wjd.v16.i11.109455).
    • APExBIO's EdU Flow Cytometry Assay Kits (Cy5) demonstrate high sensitivity, detecting as few as 1% S-phase cells in mixed populations (product page).
    • Multiplexing with antibody panels is feasible due to mild fixation/permeabilization conditions, critical for simultaneous detection of surface and intracellular antigens (internal review).
    • In studies of diabetic foot ulcer models, EdU assays accurately quantified impaired epithelial cell proliferation following DCPS knockdown; flow cytometry validated reduced S-phase entry and increased apoptosis (Xiao et al., 2025, DOI).
    • EdU (10 μM, 2-hour pulse) and Cy5 click chemistry protocols yield reproducible results with a signal-to-noise ratio >15 under standard conditions (37°C, PBS, 2% FBS) (product documentation).

    Applications, Limits & Misconceptions

    The EdU Flow Cytometry Assay Kits (Cy5) are widely used in:

    • Cancer research: Quantifying proliferation rates in tumor cell lines and primary samples (internal scenario-driven review). This article extends previous workflow guidance by adding new benchmarks for sensitivity and multiplexing.
    • Genotoxicity assessment: Measuring DNA replication stress and cell cycle arrest after exposure to chemotherapeutics or environmental toxins (Xiao et al., 2025).
    • Pharmacodynamic evaluation: Monitoring drug effects on cell cycle progression and DNA synthesis in vitro.
    • Stem cell and regenerative biology: Tracking proliferation during tissue repair or differentiation protocols (internal review). This article clarifies the molecular basis of EdU specificity not fully outlined in previous discussions.

    Common Pitfalls or Misconceptions

    • EdU toxicity: High EdU concentrations (>20 μM) or extended pulse times can induce cytotoxicity or DNA damage; always optimize for cell type.
    • Not suitable for live-cell imaging: The CuAAC reaction requires cell fixation and permeabilization; live-cell EdU detection is not possible with this kit.
    • Limited to S-phase detection: EdU incorporation only marks cells actively replicating DNA; non-proliferative cells remain unlabeled.
    • Compatibility with copper-sensitive epitopes: Some antibodies may be sensitive to residual copper; validate multiplexing panels empirically.
    • Not a substitute for functional assays: EdU staining reflects DNA synthesis, not direct cell division or viability.

    Workflow Integration & Parameters

    The EdU Flow Cytometry Assay Kits (Cy5) are supplied by APExBIO and include EdU, Cy5 azide, DMSO, CuSO4, and buffer additive. Recommended workflow:

    1. Incubate cells with EdU (10 μM, 30–120 min at 37°C) in growth medium.
    2. Fix cells with 4% paraformaldehyde (RT, 15 min), then permeabilize with 0.1% Triton X-100 (RT, 20 min).
    3. Prepare click reaction mix (CuSO4, Cy5 azide, buffer additive, DMSO) and incubate cells (RT, 30 min, protected from light).
    4. Wash cells and analyze by flow cytometry (Cy5: Ex 650 nm, Em 670 nm).
    5. Co-stain with antibodies as needed for multiplex detection.

    The kit should be stored at -20°C, protected from light/moisture, with a stability of up to one year. Detailed protocol adjustments are available in the official product documentation. For further optimizations and troubleshooting, see scenario-based guides such as this Q&A resource, which this article updates by providing new quantitative benchmarks and clarifying multiplexing compatibility issues.

    Conclusion & Outlook

    The EdU Flow Cytometry Assay Kits (Cy5) offer a robust, sensitive, and straightforward solution for S-phase cell proliferation analysis in diverse research settings. Their compatibility with multiplexed antibody detection, absence of harsh denaturation, and strong signal-to-noise ratio set them apart from legacy BrdU assays. These features are validated by both peer-reviewed research and extensive product documentation. As cell cycle and proliferation analyses continue to inform oncology, regenerative medicine, and drug development, the K1078 kit from APExBIO represents a best-practice standard for flow cytometry-based DNA synthesis detection. For expanded experimental context, consider recent internal reviews on workflow enhancement and sensitivity optimization.